How do you switch from hydrocodone (Hydrocodone bitartrate) to Suboxone (Buprenorphine and Naloxone)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 9, 2025 • View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

Switching from hydrocodone to Suboxone should be done under medical supervision, with the patient discontinuing all opioids the night before initiation and starting with a low dose of 2-4mg of Suboxone after mild withdrawal is present. This approach is based on the recommendations from a consensus panel published in the Mayo Clinic Proceedings in 2020 1. The goal is to avoid precipitated withdrawal and ensure a smooth transition.

When switching, it's essential to consider the following steps:

  • Discontinue all opioids the night before initiation, depending on the duration of action
  • Initiate Suboxone with 2-4mg after mild withdrawal is present, repeating the dose at 2-hour intervals if well tolerated, until resolution of withdrawal symptoms
  • Typically, 4-8mg of Suboxone will be needed on the first day
  • Reevaluate the patient on day 2 and increase the dose if needed, with the total dose given on day 2 becoming the daily dose

It's crucial to note that buprenorphine for analgesia should be given in 3-4 daily doses, unlike treatment for opioid use disorder 1. Additionally, clinicians should be aware of the potential for protracted withdrawal symptoms, such as dysphoria, irritability, and insomnia, which can occur months after opioid elimination and may require preemptive treatment or discussion with the patient.

The transition from hydrocodone to Suboxone requires careful medical supervision, and patients should be informed about the potential risks and benefits, including the importance of avoiding abrupt discontinuation of opioids to prevent serious withdrawal symptoms, as warned by the US Food and Drug Administration (FDA) 1.

From the Research

Switching from Hydrocodone to Suboxone

There are no direct studies on switching from hydrocodone to suboxone. However, the available evidence provides information on transitioning from one opioid to another, which can be applied to this scenario.

  • The process of switching from one opioid to another, such as from methadone to buprenorphine, can be complex and requires careful consideration of the patient's individual needs and medical history 2, 3, 4.
  • A micro-dosing protocol can be used to rapidly transition patients from methadone to buprenorphine, reducing the risk of precipitated withdrawal and opioid use during induction 2.
  • A rapid transition from methadone to subcutaneous buprenorphine depot can be safe and well-tolerated, even in patients on high doses of methadone 3.
  • The available evidence suggests that a range of innovative approaches to transferring patients from one opioid to another remains untested, and clinicians and patients need to exercise judgment when attempting transfers 4.
  • It is essential to note that switching from hydrocodone to suboxone should only be done under the guidance of a healthcare professional, as it requires careful monitoring and adjustment of doses to minimize the risk of withdrawal and other adverse effects.

Key Considerations

  • The dosage and type of opioid being switched from and to
  • The patient's medical history and individual needs
  • The risk of precipitated withdrawal and opioid use during induction
  • The need for careful monitoring and adjustment of doses
  • The importance of exercising judgment when attempting transfers 2, 3, 4.

References

1
Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

What are the ancillary medications used in the management of opioid use disorder?
What are safe alternatives to synthetic opioids for non-medical use?
What is the recommended approach for converting a patient from Butrans (buprenorphine) to Suboxone (buprenorphine with naloxone)?
Can you take Norco (hydrocodone) and buprenorphine at the same time?
What are the adverse reactions to Naloxone (Narcan) infusion?
Which of the following metastases are characteristically osteoblastic: a) Prostate, b) Lung, c) Breast, or d) Hypernephroma (Renal Cell Carcinoma)?
Where is a pulmonary consolidation located if it obscures the right cardiac border, a sign known as the silhouette sign?
What is the recommended dose of Ivermectin (antiparasitic medication) for the treatment of Lymphatic Filariasis?
What initial study is requested to confirm the diagnosis in a 30-year-old woman with anterior neck pain, fever, insomnia, palpitations, mildly enlarged and tender thyroid gland, tachycardia, and tremors?
How to document an open burn blister for a medical note?
What is the diagnosis for a patient with chronic lymphocytic leukemia (CLL), Rai stage 0, presenting with fever, sore throat, sinus pressure, purulent nasal discharge, and lymphocytosis?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ask Question